French and British researchers are finding ways to integrate nuclear magnetic resonance spectrometers into operating procedures. NMR spectroscopy allows scientists to identify the "chemical fingerprint" of biopsy samples, a process that could significantly reduce the time spent to evaluate samples. The development could help surgeons gain point-of-care feedback and increase the procedure's chance at success.

Related Summaries